An Effectiveness and Safety Study of Cyclobenzaprine HCl Alone or in Combination With Ibuprofen for Acute Back or Neck Muscle Pain With Muscle Spasm
Pain, Spasm
About this trial
This is an interventional treatment trial for Pain focused on measuring muscle spasm, cyclobenzaprine hydrochloride
Eligibility Criteria
Inclusion Criteria: Experiencing neck or back pain for no more than 14 days Physician rating of the muscle spasm of the neck or back region as mild, moderate or severe Ability to discontinue all muscle relaxants, NSAIDs (anti-inflammatory drugs) and pain relievers, other than the study medications during the 7-day treatment period. (Cardioprotective doses of aspirin (<= 325 mg / day) may be taken.) Exclusion Criteria: History of physician-diagnosed musculoskeletal neck or back muscle spasms within 12 months prior to the study neck or back pain radiating into the arms or legs history of serious medical conditions taken a narcotic or muscle relaxant within 12 hours of the baseline physician visit allergies to aspirin, NSAIDs or cyclobenzaprine HCl.